Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986075 · ClinicalTrials.gov registry record · Phase 1
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 145
- Enrollment target
NCT01986075 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 145 participants.
The verdict
NCT01986075, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 145 participants
- Enrollment target
Study Summary
This study will investigate a treatment strategy in which a computer-assisted behavioral intervention will be used to help individuals stop their use of cocaine. A medication will be combined with the behavioral treatment among those individuals who do not respond to the behavioral intervention alone. The primary hypothesis of the study is that among cocaine dependent individuals who fail to respond to an initial trial of behavioral therapy, a greater proportion of individuals will benefit from the combined treatment (behavior therapy plus medication) compared to individuals in the comparison group.
Interventions
- DRUG Placebo
- BEHAVIORAL Computer-assisted behavior therapy
- DRUG Mixed-Amphetamine Salts- Extended Release (MAS-ER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2014-01 |
| Est. Completion | 2021-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01986075
The ClinicalTrials.gov registry entry for NCT01986075 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01986075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01986075 about?
NCT01986075 is a clinical study titled "A Sequenced Behavioral and Medication Intervention for Cocaine Dependence". This study will investigate a treatment strategy in which a computer-assisted behavioral intervention will be used to help individuals stop their use of cocaine. A medication will be combined with the behavioral treatment among those individuals who do not respond to the behavioral intervention alon...
What is the current status of trial NCT01986075?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 145 participants. The study started on 2014-01. Estimated completion is 2021-01.
What interventions are being tested in trial NCT01986075?
The interventions under investigation include: Placebo (DRUG), Computer-assisted behavior therapy (BEHAVIORAL), Mixed-Amphetamine Salts- Extended Release (MAS-ER) (DRUG).
Who is sponsoring clinical trial NCT01986075?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.